http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 27 May 2026 06:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++SUN+LIFE+FINANCIAL+INC++++For%3A+May+26/26552799.html si-local-file:///var/storage/secattach/20260527/26552799.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++SUN+LIFE+FINANCIAL+INC++++For%3A+May+26/26552799.html Wed, 27 May 2026 06:01:00 -0400 O.13305384 SLF http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++SUN+LIFE+FINANCIAL+INC++++For%3A+May+26/26552799.html si-local-file:///var/storage/secattach/20260527/26552799.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++SUN+LIFE+FINANCIAL+INC++++For%3A+May+26/26552799.html Wed, 27 May 2026 06:01:00 -0400 O.13305384 SLF http://www.streetinsider.com/Press+Releases/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder4924"><p><a target="_blank" href="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.html" target="_blank" rel="nofollow"><img src="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.jpg" title="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" alt="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" /></a></p></div><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>May 26, 2026</chron></span> /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) (the "Company") announced today that the Office of the Superintendent <span>of Financial Institutions</span> ("OSFI") and the <span>Toronto Stock Exchange</span> (the "TSX") have approved the renewal of the Company's previously announced normal course issuer bid to purchase up to 10,000,000 of its common shares ("common shares") (representing approximately 1.8% of the 554,255,267 http://www.streetinsider.com/Press+Releases/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html Tue, 26 May 2026 17:01:00 -0400 O.13305384 SLF SLF http://www.streetinsider.com/Press+Releases/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder4924"><p><a target="_blank" href="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.html" target="_blank" rel="nofollow"><img src="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.jpg" title="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" alt="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" /></a></p></div><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>May 26, 2026</chron></span> /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) (the "Company") announced today that the Office of the Superintendent <span>of Financial Institutions</span> ("OSFI") and the <span>Toronto Stock Exchange</span> (the "TSX") have approved the renewal of the Company's previously announced normal course issuer bid to purchase up to 10,000,000 of its common shares ("common shares") (representing approximately 1.8% of the 554,255,267 http://www.streetinsider.com/Press+Releases/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html Tue, 26 May 2026 17:01:00 -0400 O.13305384 SLF SLF http://www.streetinsider.com/Press+Releases/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder4924"><p><a target="_blank" href="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.html" target="_blank" rel="nofollow"><img src="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.jpg" title="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" alt="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" /></a></p></div><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>May 26, 2026</chron></span> /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) (the "Company") announced today that the Office of the Superintendent <span>of Financial Institutions</span> ("OSFI") and the <span>Toronto Stock Exchange</span> (the "TSX") have approved the renewal of the Company's previously announced normal course issuer bid to purchase up to 10,000,000 of its common shares ("common shares") (representing approximately 1.8% of the 554,255,267 http://www.streetinsider.com/Press+Releases/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html Tue, 26 May 2026 17:01:00 -0400 O.13305384 SLF SLF http://www.streetinsider.com/PRNewswire/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder4924"><p><a target="_blank" href="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.html" target="_blank" rel="nofollow"><img src="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.jpg" title="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" alt="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" /></a></p></div><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>May 26, 2026</chron></span> /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) (the "Company") announced today that the Office of the Superintendent <span>of Financial Institutions</span> ("OSFI") and the <span>Toronto Stock Exchange</span> (the "TSX") have approved the renewal of the Company's previously announced normal course issuer bid to purchase up to 10,000,000 of its common shares ("common shares") (representing approximately 1.8% of the 554,255,267 http://www.streetinsider.com/PRNewswire/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html Tue, 26 May 2026 17:01:00 -0400 O.13305384 SLF SLF http://www.streetinsider.com/PRNewswire/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder4924"><p><a target="_blank" href="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.html" target="_blank" rel="nofollow"><img src="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.jpg" title="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" alt="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" /></a></p></div><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>May 26, 2026</chron></span> /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) (the "Company") announced today that the Office of the Superintendent <span>of Financial Institutions</span> ("OSFI") and the <span>Toronto Stock Exchange</span> (the "TSX") have approved the renewal of the Company's previously announced normal course issuer bid to purchase up to 10,000,000 of its common shares ("common shares") (representing approximately 1.8% of the 554,255,267 http://www.streetinsider.com/PRNewswire/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html Tue, 26 May 2026 17:01:00 -0400 O.13305384 SLF SLF http://www.streetinsider.com/PRNewswire/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder4924"><p><a target="_blank" href="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.html" target="_blank" rel="nofollow"><img src="https://mma.prnewswire.com/media/2987132/Sun_Life_Financial_Inc____Financial_News_Sun_Life_Receives_Regul.jpg" title="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" alt="Sun Life logo (CNW Group/Sun Life Financial Inc. - Financial News)" /></a></p></div><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>May 26, 2026</chron></span> /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) (the "Company") announced today that the Office of the Superintendent <span>of Financial Institutions</span> ("OSFI") and the <span>Toronto Stock Exchange</span> (the "TSX") have approved the renewal of the Company's previously announced normal course issuer bid to purchase up to 10,000,000 of its common shares ("common shares") (representing approximately 1.8% of the 554,255,267 http://www.streetinsider.com/PRNewswire/Sun+Life+Receives+Regulatory+Approval+of+Normal+Course+Issuer+Bid+Renewal/26551092.html Tue, 26 May 2026 17:01:00 -0400 O.13305384 SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.welley" idsrc="xmltag.org" >WELLESLEY, Mass.</location></span>, <span class="legendSpanClass"><chron>May 21, 2026</chron></span> /PRNewswire/ -- Sun Life <location value="LC/us" idsrc="xmltag.org" >U.S.</location> has released its annual <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4694507-1&amp;h=1965085657&amp;u=https%3A%2F%2Fsunlife.showpad.com%2Fshare%2FNrXcv0sXT1ytY0KqBRcXB&amp;a=High-Cost+Claims+and+Injectable+Drug+Trends+report" target="_blank" rel="nofollow">High-Cost Claims and Injectable Drug Trends report</a>, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report shows that secondary (comorbid) conditions, long inpatient hospitalizations and injectable drugs are the biggest drivers of claims above <money>$3 million</money>. Other contributing factors include conditions existing from birth (congenital anomalies), complicated surgeries and gene therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/What+drives+multimillion-dollar+medical+claims%3F+Sun+Life+report+shows+secondary+health+conditions%2C+hospital+stays+and+specialty+drugs+among+key+factors/26537285.html Thu, 21 May 2026 18:45:00 -0400 A.18135608 A.33081190 A.50215685 O.13305384 O.13305384 O.19727204 O.32221025 SLF SLF SLF